Home > News > From Flameout to Bargain
July 8th, 2004
From Flameout to Bargain
Abstract:
The stock of biopharmaceutical and Merrill Lynch (NYSE: MER) Nanotech Index (AMEX: NNZ) member Flamel Technologies (Nasdaq: FLML) has declined more than 50% since hitting a $43.60 all-time high in September. The stock, down 11% today on no discernible news, is not matching the 20% increase, since May, of its index peers. Although the recent stock flameout might be an indication of trouble, a closer look reveals a lot to like.
Source:
Fool.com
Related News Press |
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |